Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IGM Biosciences, Inc. - Common Stock (NQ:IGMS)

1.270 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGM Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, SPTN, IGMS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
IGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session.
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
 
Via Benzinga
What 4 Analyst Ratings Have To Say About IGM Biosciences
 
Via Benzinga
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
From IGM Biosciences, Inc.
Via GlobeNewswire
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
 
Via Benzinga
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results
 
Via Benzinga
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December
 
Via Benzinga
Topics Economy Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
US Stocks To Open On A Tentative Note As Traders Remain Cautious Ahead Of Friday's Crucial Jobs Data
U.S. stock futures were on a mixed note on Friday ahead of the crucial U.S. jobs data report after a mixed close in the previous session. 
Via Benzinga
Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Crude Oil Up 2%; Siyata Mobile Shares Jump
 
Via Benzinga
Dow Dips Over 300 Points; Viad Shares Spike Higher
 
Via Benzinga
Topics Stocks
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Topics Government
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
IGM Biosciences shifts focus to autoimmune diseases, reduces oncology research, and appoints former Bristol Myers Squibb executive as CEO. The company aims to extend its cash runway into 2027. 
Via Benzinga
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
The company is making a complete shift out of oncology and into autoimmune diseases. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
From IGM Biosciences, Inc.
Via GlobeNewswire
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperforming their larger-cap counterparts. However, potential for gains may be hindered by sluggish... 
Via Benzinga
Topics Economy Stocks
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
From IGM Biosciences, Inc.
Via GlobeNewswire
IGMS Stock Earnings: IGM Biosciences Misses EPS, Misses Revenue for Q2 2024
IGMS stock results show that IGM Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.